DK0712426T3 - Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf - Google Patents

Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf

Info

Publication number
DK0712426T3
DK0712426T3 DK94922905.8T DK94922905T DK0712426T3 DK 0712426 T3 DK0712426 T3 DK 0712426T3 DK 94922905 T DK94922905 T DK 94922905T DK 0712426 T3 DK0712426 T3 DK 0712426T3
Authority
DK
Denmark
Prior art keywords
fluorochromes
preparation
fluorescent latex
latex
fluorescent
Prior art date
Application number
DK94922905.8T
Other languages
Danish (da)
English (en)
Inventor
Sophie Vaslin
Joel Richard
Dominique Teychenne
Frederic Ricchiero
Dan Lerner
Original Assignee
Prolabo Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolabo Sa filed Critical Prolabo Sa
Application granted granted Critical
Publication of DK0712426T3 publication Critical patent/DK0712426T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0041—Optical brightening agents, organic pigments
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00—Use of pretreated ingredients
    • C08K9/10—Encapsulated ingredients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK94922905.8T 1993-07-12 1994-07-11 Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf DK0712426T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308573A FR2707658B1 (fr) 1993-07-12 1993-07-12 Latex fluorescent comportant au moins deux fluorochromes, procédé d'obtention et application dudit latex comme marqueur, notamment en biologie.

Publications (1)

Publication Number Publication Date
DK0712426T3 true DK0712426T3 (da) 1997-12-22

Family

ID=9449186

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94922905.8T DK0712426T3 (da) 1993-07-12 1994-07-11 Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf

Country Status (10)

Country Link
US (1) US5716855A (de)
EP (1) EP0712426B1 (de)
JP (1) JPH09504041A (de)
CA (1) CA2167072C (de)
DE (1) DE69403663T2 (de)
DK (1) DK0712426T3 (de)
ES (1) ES2104405T3 (de)
FR (1) FR2707658B1 (de)
NO (1) NO308253B1 (de)
WO (1) WO1995002635A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251581B1 (en) 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
US5578498A (en) 1991-05-22 1996-11-26 Behringwerke Ag Metal chelate containing compositions for use in chemiluminescent assays
US6238931B1 (en) * 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
GB9602265D0 (en) * 1996-02-05 1996-04-03 Amersham Int Plc Benzophenoxazine dyes
JP3338616B2 (ja) * 1996-09-05 2002-10-28 富士通株式会社 蛍光体層の形成方法及び蛍光体ペースト
IL135593A (en) 1997-10-14 2004-06-01 Luminex Corp Precisely fluorescently painted polymeric microspheres and methods for making and using them
JP2002504689A (ja) 1998-02-18 2002-02-12 デイド・ベーリング・インコーポレイテッド 複数の検体の検出において使用するための化学ルミネセンス組成物
US6642062B2 (en) * 1998-09-03 2003-11-04 Trellis Bioinformatics, Inc. Multihued labels
WO2000014545A1 (en) * 1998-09-03 2000-03-16 Trellis Bioinformatics, Inc. Multihued labels
US6703248B1 (en) * 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
US20050164261A1 (en) * 2001-10-09 2005-07-28 Chandler Don J. Multiplexed analysis of clinical specimens apparatus and methods
US8148171B2 (en) 2001-10-09 2012-04-03 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
WO2005003182A2 (en) * 2003-07-02 2005-01-13 Perkinelmer Las, Inc. Scintillator composition for a radioassay, and method for its use
US7407816B2 (en) * 2004-05-07 2008-08-05 Gentius, Inc Isoelectric particles and uses thereof
US20080077002A1 (en) * 2004-09-10 2008-03-27 Koninklijke Philips Electronics, N.V. Compounds and Methods for Combined Optical-Ultrasound Imaging
JP2008538609A (ja) * 2005-04-20 2008-10-30 ベクトン・ディキンソン・アンド・カンパニー マルチプレックスマイクロ粒子システム
US7939613B2 (en) * 2005-04-22 2011-05-10 The Hong Kong University Of Science And Technology Fluorescent water-soluble conjugated polyene compounds that exhibit aggregation induced emission and methods of making and using same
NO20053373D0 (no) * 2005-07-11 2005-07-11 Rikshospitalet Radiumhospitale Multicolored Particles.
EP2393848A1 (de) 2009-02-09 2011-12-14 Merck Patent GmbH Gefärbte partikel für elektrophoretische anzeigen
US8743451B2 (en) 2009-02-09 2014-06-03 Merck Patent Gmbh Coloured particles for electrophoretic displays
KR101796796B1 (ko) 2009-02-09 2017-11-10 메르크 파텐트 게엠베하 전기영동 디스플레이용 착색 입자
US8593719B2 (en) 2009-02-09 2013-11-26 Merck Patent Gmbh Particles for electrophoretic displays
GB2475226A (en) * 2009-11-03 2011-05-18 Genetic Analysis As Universal Prokaryote 16S ribosome PCR primer pair
GB201021397D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Diagnosis of Crohn's disease
GB201021399D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Oligonucleotide probe set and methods of microbiota profiling
GB201102693D0 (en) 2011-02-16 2011-03-30 Genetic Analysis As Method for identifying neonates at risk for necrotizing enterocolitis
US9227181B2 (en) 2011-09-13 2016-01-05 Basf Corporation Catalyst to increase propylene yields from a fluid catalytic cracking unit
WO2014166583A1 (en) 2013-04-12 2014-10-16 Merck Patent Gmbh Particles for electrophoretic displays
WO2016096091A1 (en) 2014-12-19 2016-06-23 Merck Patent Gmbh Particles for electrophoretic displays
CN109642901A (zh) * 2016-08-31 2019-04-16 积水化学工业株式会社 诊断试剂用荧光粒子及使用其的免疫测定试剂
WO2021173312A1 (en) 2020-02-24 2021-09-02 Corning Incorporated Calibration set including nanoparticles of nylon-6 and dyes
CN111363539A (zh) * 2020-04-30 2020-07-03 上海思滤科技有限公司 一种单分散多色发光微球及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3000483A1 (de) * 1979-01-09 1980-07-17 Fuji Photo Film Co Ltd Mikrokapseln fuer immunologische bestimmungen
US5073497A (en) * 1989-06-30 1991-12-17 Caribbean Microparticles Corporation Microbead reference standard and method of adjusting a flow cytometer to obtain reproducible results using the microbeads
EP0280556B1 (de) * 1987-02-27 1994-08-10 EASTMAN KODAK COMPANY (a New Jersey corporation) Wasserunlösliches Teilchen und immunoreaktives Reagens, analytische Elemente und Verfahren zu ihrer Verwendung
US5607864A (en) * 1992-04-07 1997-03-04 Societe Prolabo Fluorescent latices having very low detection thresholds for fluorescent emission
US5264960A (en) * 1992-05-08 1993-11-23 At&T Bell Laboratories Optical wavelength shifter
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
US5393527A (en) * 1993-01-04 1995-02-28 Becton, Dickinson And Company Stabilized microspheres and methods of preparation

Also Published As

Publication number Publication date
US5716855A (en) 1998-02-10
CA2167072A1 (fr) 1995-01-26
WO1995002635A1 (fr) 1995-01-26
EP0712426B1 (de) 1997-06-04
NO960123L (no) 1996-03-12
DE69403663D1 (de) 1997-07-10
EP0712426A1 (de) 1996-05-22
NO308253B1 (no) 2000-08-21
JPH09504041A (ja) 1997-04-22
FR2707658B1 (fr) 1995-11-24
DE69403663T2 (de) 1998-01-02
ES2104405T3 (es) 1997-10-01
FR2707658A1 (fr) 1995-01-20
NO960123D0 (no) 1996-01-11
CA2167072C (fr) 2008-10-28

Similar Documents

Publication Publication Date Title
DK0712426T3 (da) Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf
FI934779L (fi) Foerankringselement som stoeder en protes eller en ledmekanism, avsett foer rekonstruerad led
FI905958A7 (fi) Foerfarande foer framstaellning av substituerade cyklohexanoler, som verkar pao det centrala nervsystemet.
BR9601093A (pt) Pirido(3,2-E)pirazinoas processo para sua preparação medicamentos processo para sua preparação e utilização
FI931278A0 (fi) Polymerer, som innehaoller sulfogrupper
FI970094L (fi) Substituoidut bentsamidiinit, niiden valmistus ja käyttö lääkeaineena
FI900625A0 (fi) Laekemedel innehaollande dihydroliponsyra som aktivt aemne.
FI921279A0 (fi) Amino-b-lyasenzyminhibitorer som deodoranter.
FI891438L (fi) Foerfarande foer framstaellning av farmaceutiska sammansaettningar som inverkar i synnerhet pao det kardiovaskulaera systemet.
FI905663A7 (fi) Foerfarande foer erhaollande av pyridazinderivat, vilka aer anvaendbara som lignder av acetylkolinaktiga receptorer.
EP0778267A4 (de) Sulfonamid-derivate enthaltende insektizide, mitizide und nematizide
NO960364D0 (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
FI900763A0 (fi) Tris-hydroximetyl-laegre alkanestrar som fettsurrogat.
DK539087D0 (da) 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolooe1,5-aaapyrimidiner, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DK135988D0 (da) 2,5-dihydropyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider
FI901508A0 (fi) Maskin foer automatisk applicering av en elastisk taetning, saerskilt foer en glasruta eller en tillslutningslist.
FI905957A7 (fi) Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet.
ITRM930697A0 (it) Composti azoici, loro preparazione e loro impiego come coloranti dispersi. (caso 150-5673).
FI892939L (fi) Polynukleotidfosforylas som aer immobiliserat pao epoxiaktiverade baeddar.
NO890096D0 (no) Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter.
BR9600779A (pt) Benzenossulfoniluréias e -tioréias substituidas processo para sua preparação uso e medicamento
FI893225L (fi) Behandling av gaser som innehaoller halogenfoereningar.
NO910039D0 (no) Ikke-beskadigende overhalings- og fullfoeringsfluid.
ATA29693A (de) Versenkung, insbesondere verfahrbare einzelversenkung
FI930217A7 (fi) Hoegt tvaerbundna, smaott avdunstande organiska foereningar innehaollande ytbelaeggningskompositioner som omfattar polyuretandispersioner